-
Abbink P, Larocca RA, De La Barrera RA, Bricault CA, Moseley ET, Boyd M, Kirilova M, Li Z, Ng'ang'a D, Nanayakkara O, Nityanandam R, Mercado NB, Borducchi EN, Agarwal A, Brinkman AL, Cabral C, Chandrashekar A, Giglio PB, Jetton D, Jimenez J, Lee BC, Mojta S, Molloy K, Shetty M, Neubauer GH, Stephenson KE, Peron JPS, Zanotto PMdA, Misamore J, Finneyfrock B, Lewis MG, Alter G, Modjarrad K, Jarman RG, Eckels KH, Michael NL, Thomas SJ, Barouch DH, 2016: Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys[J]. Science, 353, 1129-1132. doi: 10.1126/science.aah6157
-
Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX, 1995: Synthesis and secretion of recombinant tick-borne encephalitis-virus protein-e in soluble and particulate form[J]. J Virol, 69, 5816-5820.
-
Boigard H, Alimova A, Martin GR, Al K, Gottlieb P, Galarza JM, 2017: Zika virus-like particle (VLP) based vaccine[J]. PLoS Negl Trop Dis, 11, e0005608-. doi: 10.1371/journal.pntd.0005608
-
Ch'ng WC, Saw WT, Yusoff K, Shafee N, 2011: Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice[J]. Acta Virol, 55, 227-233. doi: 10.4149/av_2011_03_227
-
Dai L, Song J, Lu X, Deng YQ, Musyoki AM, Cheng H, Zhang Y, Yuan Y, Song H, Haywood J, Xiao H, Yan J, Shi Y, Qin CF, Qi J, Gao GF, 2016: Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody[J]. Cell Host Microbe, 19, 696-704. doi: 10.1016/j.chom.2016.04.013
-
de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM, 2012: Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions[J]. Proc Natl Acad Sci USA, 109, 7439-7444. doi: 10.1073/pnas.1200566109
-
Del Prete G, Romagnani S, 1994: The role of TH1 and TH2 subsets in human infectious diseases[J]. Trends Microbiol, 2, 4-6. doi: 10.1016/0966-842X(94)90336-0
-
Deng F, Wang R, Fang M, Jiang Y, Xu X, Wang H, Chen X, Arif BM, Guo L, Wang H, Hu Z, 2007: Proteomics analysis of Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus identified two new occlusion-derived virus-associated proteins, HA44 and HA100[J]. J Virol, 81, 9377-9385. doi: 10.1128/JVI.00632-07
-
Deng C, Liu S, Zhang Q, Xu M, Zhang H, Gu D, Shi L, He J, Xiao G, Zhang B, 2016: Isolation and characterization of Zika virus imported to China using C6/36 mosquito cells[J]. Virol Sin, 31, 176-179. doi: 10.1007/s12250-016-3778-5
-
Dick GWA, Kitchen SF, Haddow AJ, 1952: Zika virus.I. isolations and serological specificity[J]. Trans R Soc Trop Med Hyg, 46, 509-520. doi: 10.1016/0035-9203(52)90042-4
-
Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith ARY, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, Diamond MS, Ledgerwood JE, Pierson TC, 2016a: Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype[J]. Cell Rep, 16, 1485-1491. doi: 10.1016/j.celrep.2016.07.049
-
Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS, DeMaso CR, Castilho LR, Abbink P, Boyd M, Nityanandam R, Gordon DN, Gallagher JR, Chen X, Todd JP, Tsybovsky Y, Harris A, Huang Y-JS, Higgs S, Vanlandingham DL, Andersen H, Lewis MG, De La Barrera R, Eckels KH, Jarman RG, Nason MC, Barouch DH, Roederer M, Kong WP, Mascola JR, Pierson TC, Graham BS, 2016b: Rapid development of a DNA vaccine for Zika virus[J]. Science, 354, 237-240. doi: 10.1126/science.aai9137
-
Du R, Yin F, Wang M, Hu Z, Wang H, Deng F, 2015: Glycoprotein E of the Japanese encephalitis virus forms virus-like particles and induces syncytia when expressed by a baculovirus[J]. J Gen Virol, 96, 1006-1014. doi: 10.1099/vir.0.000052
-
Durbin A, 2016: Vaccine development for Zika virus-timelines and strategies[J]. Semin Reprod Med, 34, 299-304. doi: 10.1055/s-0036-1592070
-
Durbin A, Wilder-Smith A, 2017: An update on Zika vaccine developments[J]. Expert Rev Vaccines, 16, 781-787. doi: 10.1080/14760584.2017.1345309
-
Garg H, Sedano M, Plata G, Punke EB, Joshi A, 2017: Development of virus-like-particle vaccine and reporter assay for Zika virus[J]. J Virol, 91, e00834-17.
-
Heinz FX, Stiasny K, 2012: Flaviviruses and their antigenic structure[J]. J Clin Virol, 55, 289-295. doi: 10.1016/j.jcv.2012.08.024
-
Jarvis DL, 2003: Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production[J]. Virology, 310, 1-7. doi: 10.1016/S0042-6822(03)00120-X
-
Larocca RA, Abbink P, Peron JPS, Zanotto PMdA, Iampietro MJ, Badamchi-Zadeh A, Boyd M, Ng'ang'a D, Kirilova M, Nityanandam R, Mercado NB, Li Z, Moseley ET, Bricault CA, Borducchi EN, Giglio PB, Jetton D, Neubauer G, Nkolola JP, Maxfield LF, De La Barrera RA, Jarman RG, Eckels KH, Michael NL, Thomas SJ, Barouch DH, 2016: Vaccine protection against Zika virus from Brazil[J]. Nature, 536, 474-478. doi: 10.1038/nature18952
-
Lessler J, Chaisson LH, Kucirka LM, Bi Q, Grantz K, Salje H, Carcelen AC, Ott CT, Sheffield JS, Ferguson NM, Cummings DAT, Metcalf CJE, Rodriguez-Barraquer I, 2016: Assessing the global threat from Zika virus[J]. Science, 353, aaf8160-. doi: 10.1126/science.aaf8160
-
Liu J, Dai S, Wang M, Hu Z, Wang H, Deng F, 2016: Virus like particle-based vaccines against emerging infectious disease viruses[J]. Virol Sin, 31, 279-287. doi: 10.1007/s12250-016-3756-y
-
Mani S, Tripathi L, Raut R, Tyagi P, Arora U, Barman T, Sood R, Galav A, Wahala W, de Silva A, Swaminathan S, Khanna N, 2013: Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies[J]. PLoS ONE, 8, e64595-. doi: 10.1371/journal.pone.0064595
-
Miner JJ, Cao B, Govero J, Smith AM, Fernandez E, Cabrera OH, Garber C, Noll M, Klein RS, Noguchi KK, Mysorekar IU, Diamond MS, 2016: Zika virus infection during pregnancy in mice causes placental damage and fetal demise[J]. Cell, 165, 1080-1090.
-
Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, Kolenc M, Rus KR, Vipotnik TV, Vodusek VF, Vizjak A, Pizem J, Petrovec M, Zupanc TA, 2016: Zika virus associated with microcephaly[J]. N Engl J Med, 374, 951-958. doi: 10.1056/NEJMoa1600651
-
Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, Wagner W, Granados A, Greenhouse J, Walker M, Willis E, Yu JS, McGee CE, Sempowski GD, Mui BL, Tam YK, Huang YJ, Vanlandingham D, Holmes VM, Balachandran H, Sahu S, Lifton M, Higgs S, Hensley SE, Madden TD, Hope MJ, Kariko K, Santra S, Graham BS, Lewis MG, Pierson TC, Haynes BF, Weissman D, 2017: Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination[J]. Nature, 543, 248-251. doi: 10.1038/nature21428
-
Pierson TC, Graham BS, 2016: Zika virus: immunity and vaccine development[J]. Cell, 167, 625-631. doi: 10.1016/j.cell.2016.09.020
-
Prasad VM, Miller AS, Klose T, Sirohi D, Buda G, Jiang W, Kuhn RJ, Rossmann MG, 2017: Structure of the immature Zika virus at 9 A resolution[J]. Nat Struct Mol Biol, 24, 184-186. doi: 10.1038/nsmb.3352
-
Rodriguez-Limas WA, Sekar K, Tyo KE, 2013: Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development[J]. Curr Opin Biotechnol, 24, 1089-1093. doi: 10.1016/j.copbio.2013.02.008
-
Rudd PM, Wormald MR, Stanfield RL, Huang MD, Mattsson N, Speir JA, DiGennaro JA, Fetrow JS, Dwek RA, Wilson IA, 1999: Roles for glycosylation of cell surface receptors involved in cellular immune recognition[J]. J Mol Biol, 293, 351-366. doi: 10.1006/jmbi.1999.3104
-
Shan C, Muruato AE, Nunes BTD, Luo H, Xie X, Medeiros DBA, Wakamiya M, Tesh RB, Barrett AD, Wang T, Weaver SC, Vasconcelos PFC, Rossi SL, Shi PY, 2017: A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models[J]. Nat Med, 23, 763-767. doi: 10.1038/nm.4322
-
Shang W, Liu J, Yang J, Hu Z, Rao X, 2012: Dengue virus-like particles: construction and application[J]. Appl Microbiol Biotechnol, 94, 39-46. doi: 10.1007/s00253-012-3958-7
-
Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG, Kuhn RJ, 2016: The 3[J]. 8 angstrom resolution cryo-EM structure of Zika virus. Science, 352, 467-470.
-
Vanlent JWM, Groenen JTM, Klingeroode EC, Rohrmann GF, Zuidema D, Vlak JM, 1990: Localization of the 34kda polyhedron envelope protein in spodoptera-frugiperda cells infected with autographa-californica nuclear polyhedrosis-virus[J]. Arch Virol, 111, 103-114. doi: 10.1007/BF01310508
-
Wang M, Tan Y, Yin F, Deng F, Vlak JM, Hu Z, Wang H, 2008: The F-like protein Ac23 enhances the infectivity of the budded virus of gp64-null Autographa californica multinucleocapsid nucleopolyhedrovirus pseudotyped with baculovirus envelope fusion protein F[J]. J Virol, 82, 9800-9804. doi: 10.1128/JVI.00759-08
-
Yang M, Lai H, Sun H, Chen Q, 2017: Virus-like particles that display Zika virus envelope protein domain Ⅲ induce potent neutralizing immune responses in mice[J]. Sci Rep, 7, 7679-. doi: 10.1038/s41598-017-08247-9
-
Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, Chipman PR, Kuhn RJ, Rossmann MG, Chen J, 2008: Structure of the immature dengue virus at low pH primes proteolytic maturation[J]. Science, 319, 1834-1837. doi: 10.1126/science.1153264
-
Zeltins A, 2013: Construction and characterization of virus-like particles: a review[J]. Mol Biotechnol, 53, 92-107. doi: 10.1007/s12033-012-9598-4
-
Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak D, Baker TS, Strauss JH, Kuhn RJ, Rossmann MG, 2003: Structures of immature flavivirus particles[J]. EMBO J, 22, 2604-2613. doi: 10.1093/emboj/cdg270